Cargando…
Development and Validation of a (18)F-FDG PET-Based Radiomic Model for Evaluating Hypermetabolic Mediastinal–Hilar Lymph Nodes in Non-Small-Cell Lung Cancer
BACKGROUND: Accurate evaluation of lymph node (LN) status is critical for determining the treatment options in patients with non-small cell lung cancer (NSCLC). This study aimed to develop and validate a (18)F-FDG PET-based radiomic model for the identification of metastatic LNs from the hypermetabo...
Autores principales: | Ouyang, Ming-li, Wang, Yi-ran, Deng, Qing-shan, Zhu, Ye-fei, Zhao, Zhen-hua, Wang, Ling, Wang, Liang-xing, Tang, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457532/ https://www.ncbi.nlm.nih.gov/pubmed/34568038 http://dx.doi.org/10.3389/fonc.2021.710909 |
Ejemplares similares
-
Diagnostic value of dynamic (18)F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes
por: Sun, Yishan, et al.
Publicado: (2023) -
Evaluation of hypermetabolic mediastinal-hilar lymph nodes determined by PET/CT with EBUS-TBNA and calculation of SUVmax cutoff values in differentiation of malignancy
por: Ugurlu, Erhan, et al.
Publicado: (2023) -
Hypermetabolic Hurthle Cell Adenoma on (18)F-FDG PET/CT
por: Hassan, Aamna, et al.
Publicado: (2018) -
The Differentiation of Metastatic Mediastinal Lymph Nodes From Benign Hypermetabolic Lesions
por: Bulut, Sertan, et al.
Publicado: (2022) -
Transient (18)FDG-avid hilar lymph node on PET/CT imaging in asymptomatic COVID-19
por: Karimi-Galougahi, Mahboobeh, et al.
Publicado: (2020)